JP2008501716A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008501716A5 JP2008501716A5 JP2007515646A JP2007515646A JP2008501716A5 JP 2008501716 A5 JP2008501716 A5 JP 2008501716A5 JP 2007515646 A JP2007515646 A JP 2007515646A JP 2007515646 A JP2007515646 A JP 2007515646A JP 2008501716 A5 JP2008501716 A5 JP 2008501716A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament
- syndrome
- disease
- autoinflammatory
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57702304P | 2004-06-04 | 2004-06-04 | |
| US60/577,023 | 2004-06-04 | ||
| PCT/US2005/019674 WO2005117945A1 (en) | 2004-06-04 | 2005-06-03 | Methods of using il-1 antagonists to treat autoinflammatory disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012012800A Division JP2012111768A (ja) | 2004-06-04 | 2012-01-25 | 自己炎症性疾患を処置するためのｉｌ−１アンタゴニストを使用する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008501716A JP2008501716A (ja) | 2008-01-24 |
| JP2008501716A5 true JP2008501716A5 (https=) | 2008-04-24 |
| JP5022216B2 JP5022216B2 (ja) | 2012-09-12 |
Family
ID=34972252
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007515646A Expired - Fee Related JP5022216B2 (ja) | 2004-06-04 | 2005-06-03 | 自己炎症性疾患を処置するためのｉｌ−１アンタゴニストを使用する方法 |
| JP2012012800A Pending JP2012111768A (ja) | 2004-06-04 | 2012-01-25 | 自己炎症性疾患を処置するためのｉｌ−１アンタゴニストを使用する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012012800A Pending JP2012111768A (ja) | 2004-06-04 | 2012-01-25 | 自己炎症性疾患を処置するためのｉｌ−１アンタゴニストを使用する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US7459426B2 (https=) |
| EP (1) | EP1750746A1 (https=) |
| JP (2) | JP5022216B2 (https=) |
| CN (1) | CN1964737B (https=) |
| AU (1) | AU2005249570B2 (https=) |
| CA (1) | CA2568352C (https=) |
| IL (1) | IL179512A0 (https=) |
| MX (2) | MXPA06014126A (https=) |
| WO (1) | WO2005117945A1 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1720893B1 (en) * | 2004-02-26 | 2014-08-13 | Baylor Research Institute | Compositions and methods for the systemic treatment of arthritis |
| CA2567080A1 (en) * | 2004-05-27 | 2005-12-15 | Vertex Pharmaceuticals Incorporated | Ice inhibitors for the treatment of autoinflammatory diseases |
| WO2006076673A2 (en) * | 2005-01-14 | 2006-07-20 | Regeneron Pharmaceuticals, Inc. | Use of il-i antagonists to treat polymyalgia rheumatica and giant cell arteritis |
| PL1940465T3 (pl) * | 2005-10-26 | 2013-01-31 | Novartis Ag | Nowe zastosowanie przeciwciał anty-IL-1beta |
| CN101374964B (zh) * | 2005-12-09 | 2013-07-17 | 贝勒研究院 | 外周血液白细胞转录模式的模块水平分析 |
| US7632490B2 (en) | 2006-10-20 | 2009-12-15 | Regeneron Pharmaceuticals, Inc. | Use of IL-1 antagonists to treat gout |
| JP5397948B2 (ja) * | 2006-10-20 | 2014-01-22 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 痛風および偽痛風を治療するための、ｉｌ−１アンタゴニストの使用 |
| JP5272735B2 (ja) * | 2007-01-30 | 2013-08-28 | 国立大学法人 新潟大学 | 生物学的製剤 |
| WO2008112772A2 (en) * | 2007-03-14 | 2008-09-18 | Baylor Research Institute | Gene expression in peripheral blood mononuclear cells from children with diabetes |
| CN104873972A (zh) * | 2007-05-29 | 2015-09-02 | 诺华股份有限公司 | 抗IL-1β治疗的新适应症 |
| US20120301463A1 (en) | 2009-09-30 | 2012-11-29 | President And Fellows Of Harvard College | Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products |
| EP2582391B1 (en) | 2010-06-18 | 2018-10-03 | XBiotech, Inc | Arthritis treatment |
| ES2952394T3 (es) | 2010-07-29 | 2023-10-31 | Buzzard Pharmaceuticals AB | Antagonistas quiméricos del receptor IL-1 de tipo I |
| CU23923B1 (es) * | 2010-11-12 | 2013-07-31 | Ct De Inmunología Molecular | Polipéptidos derivados de la il-2 con actividad agonista |
| AU2012375257B2 (en) * | 2012-03-31 | 2019-09-12 | R-Pharm International, Limited Liability Company | Osteoprotegerin derived composition and use thereof |
| CN103509100B (zh) * | 2012-06-15 | 2017-10-27 | 上海百迈博制药有限公司 | 一种白细胞介素‑1受体拮抗剂突变体 |
| WO2014035361A1 (en) * | 2012-08-26 | 2014-03-06 | R-PHARM, CJSC (Closed Joint Stock Company) | IL-1β INHIBITOR COMPOSITION AND USE THEREOF |
| EP2968468B1 (en) | 2013-03-13 | 2021-07-14 | Buzzard Pharmaceuticals AB | Chimeric cytokine formulations for ocular delivery |
| WO2014194166A1 (en) * | 2013-05-31 | 2014-12-04 | Regeneron Pharmaceuticals, Inc. | Methods of using il-1 antagonists to treat alzheimer's disease |
| HK1225740A1 (zh) * | 2013-08-22 | 2017-09-15 | Acceleron Pharma Inc. | TGF-β受体II型变体及其用途 |
| WO2015147789A1 (en) * | 2014-03-24 | 2015-10-01 | R-Pharm Overseas, Inc. | Human il 1-r1 derived inhibitor of il-1b |
| JP6565099B2 (ja) * | 2015-09-18 | 2019-08-28 | 国立大学法人 長崎大学 | 家族性地中海熱のバイオマーカー |
| JP6981973B2 (ja) * | 2015-10-01 | 2021-12-17 | ヒート バイオロジクス，インコーポレイテッド | Ｉ型及びｉｉ型細胞外ドメインを異種キメラタンパク質として連結する組成物及び方法 |
| JP6840775B2 (ja) * | 2016-03-09 | 2021-03-10 | シュ・サン−ジュスティーヌ | 周産期罹病および／または死亡を減少させるための方法 |
| EP3582813A4 (en) * | 2017-02-16 | 2020-12-30 | XBiotech, Inc | TREATMENT OF SUPPURATIVE HIDRADENITIS |
| KR20190130643A (ko) * | 2017-04-03 | 2019-11-22 | 위스콘신 얼럼나이 리서어치 화운데이션 | 생물학적 활성 분자의 지속적인 전달을 위한 미네랄 코팅된 마이크로입자 |
| EP3908613A4 (en) * | 2019-01-07 | 2022-10-19 | Celluris Participações Ltda. | BISPECIFIC IN-TANDEM RECEPTOR CAR AND METHODS FOR MODULATION OF THE TUMOR MICROAREA |
| CN114599356A (zh) * | 2019-11-07 | 2022-06-07 | 英夫拉索姆有限公司 | 自身炎症性病症的治疗 |
| JP7072260B2 (ja) * | 2019-12-27 | 2022-05-20 | 国立大学法人愛媛大学 | マックル・ウェルズ症候群の治療用医薬組成物 |
| WO2021184128A1 (en) * | 2020-03-20 | 2021-09-23 | Institut De Cardiologie De Montreal | Methods of treating a coronavirus infection using colchicine |
| TW202210068A (zh) * | 2020-06-05 | 2022-03-16 | 美商雅力思提雅治療公司 | 用於治療家族性地中海型發熱病的cxcr-2抑制劑 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4980286A (en) | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
| US6927044B2 (en) * | 1998-09-25 | 2005-08-09 | Regeneron Pharmaceuticals, Inc. | IL-1 receptor based cytokine traps |
| US6472179B2 (en) | 1998-09-25 | 2002-10-29 | Regeneron Pharmaceuticals, Inc. | Receptor based antagonists and methods of making and using |
| EP1712239A3 (en) * | 2000-05-12 | 2007-08-22 | Immunex Corporation | Interleukin-1 inhibitors in the treatment of diseases |
| KR101317045B1 (ko) | 2002-09-06 | 2013-10-16 | 암젠 인코포레이티드 | 치료학적 인체 항-ｉｌ-1ｒ1 모노클로날 항체 |
| US20050129685A1 (en) * | 2003-09-18 | 2005-06-16 | Jingtai Cao | Use of IL-1 blockers to prevent corneal inflammation and neovascularization |
-
2005
- 2005-06-03 EP EP05758854A patent/EP1750746A1/en not_active Withdrawn
- 2005-06-03 MX MXPA06014126A patent/MXPA06014126A/es active IP Right Grant
- 2005-06-03 JP JP2007515646A patent/JP5022216B2/ja not_active Expired - Fee Related
- 2005-06-03 CN CN2005800182189A patent/CN1964737B/zh not_active Expired - Lifetime
- 2005-06-03 CA CA2568352A patent/CA2568352C/en not_active Expired - Fee Related
- 2005-06-03 US US11/144,987 patent/US7459426B2/en not_active Expired - Lifetime
- 2005-06-03 WO PCT/US2005/019674 patent/WO2005117945A1/en not_active Ceased
- 2005-06-03 AU AU2005249570A patent/AU2005249570B2/en not_active Ceased
-
2006
- 2006-11-23 IL IL179512A patent/IL179512A0/en unknown
- 2006-12-04 MX MX2011009567A patent/MX344967B/es unknown
-
2008
- 2008-10-28 US US12/259,366 patent/US20090156492A1/en not_active Abandoned
-
2011
- 2011-08-31 US US13/222,759 patent/US20110311537A1/en not_active Abandoned
- 2011-09-02 US US13/224,372 patent/US8414876B2/en not_active Expired - Fee Related
-
2012
- 2012-01-25 JP JP2012012800A patent/JP2012111768A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008501716A5 (https=) | ||
| Kopf et al. | Averting inflammation by targeting the cytokine environment | |
| CA2568352A1 (en) | Methods of using il-1 antagonists to treat autoinflammatory disease | |
| Malcova et al. | IL-1 inhibitors in the treatment of monogenic periodic fever syndromes: from the past to the future perspectives | |
| Assier et al. | Interleukin-6: from identification of the cytokine to development of targeted treatments | |
| Nishimoto | Interleukin‐6 as a therapeutic target in candidate inflammatory diseases | |
| ES2660036T3 (es) | Moléculas de anticuerpo humanizadas específicas para IL-31 | |
| Izuhara et al. | IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies | |
| JP2009539349A5 (https=) | ||
| Geyer et al. | Actual status of antiinterleukin-1 therapies in rheumatic diseases | |
| JP2011507891A5 (https=) | ||
| CN1322897C (zh) | Il－18抑制剂的应用 | |
| JP2017079785A5 (https=) | ||
| Tanasescu et al. | Advances in the treatment of relapsing-remitting multiple sclerosis | |
| HRP20150790T1 (hr) | Režimi imunoterapije koji ovise o statusu apoe | |
| JP2009510025A5 (https=) | ||
| JP2006506465A5 (https=) | ||
| ME00519B (me) | Antitijela visokog afiniteta prema humanom il-6 receptoru | |
| Lopalco et al. | Canakinumab efficacy in refractory adult-onset PFAPA syndrome. | |
| US10456456B2 (en) | Anti-IL-6 vaccine composition | |
| McDermott | Rilonacept in the treatment of chronic inflammatory disorders | |
| Finckh et al. | At the horizon of innovative therapy in rheumatology: new biologic agents | |
| Çakan et al. | Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases | |
| Scharl et al. | new anti-cytokines for IBD: what is in the pipeline? | |
| JP2006508039A5 (https=) |